 | ANDERS GLENTHØJFrom Medical Department B and Department of Pathology, Frederiksborg Central Hospital, Hillerød, Denmark |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
ANDERS GLENTHØJ:Expert Impact
Concepts for whichANDERS GLENTHØJhas direct influence:Necrolytic migratory erythema,Migratory erythema,Necrolytic migratory,Publication adenoma,Erythema glucagonoma,Islet cell,Glucagonoma humans,Adenoma islet.
ANDERS GLENTHØJ:KOL impact
Concepts related to the work of other authors for whichfor which ANDERS GLENTHØJ has influence:Necrolytic migratory erythema,Glucagonoma syndrome,Islet cell tumors,Octreotide acetate,21 patients,Subcutaneous injection,Nme diabetes mellitus.
KOL Resume for ANDERS GLENTHØJ
| Year | |
|---|---|
| 1985 | From Medical Department B and Department of Pathology, Frederiksborg Central Hospital, Hillerød, Denmark |
| Concept | World rank |
|---|---|
| erythema glucagonoma | #36 |
| Sign-in to see all concepts, it's free! | |
Prominent publications by ANDERS GLENTHØJ
A 63-year-old woman with necrolytic migratory erythema associated with a glucagonoma in the pancreas is described. The diagnosis was suggested on the basis of a characteristic lesion in skin biopsy. Infusion of somatostatin (25 micrograms/h) for 48 hours was followed by a rapid and almost complete healing of the skin eruptions. Serum glucagon was depressed during infusion. No significant changes in plasma glucose were detected. As the patient experienced a cramp-like sensation after ...
| Known for Necrolytic Migratory Erythema | Publication Adenoma | Islet Cell | Glucagonoma Humans | Pancreatic Neoplasms |
